Boris Marjanovic
Contributor since: 2012
Latest Articles
Semler Scientific: The Ultimate Growth At A Reasonable Price Stock
Pro-Dex Is An Undervalued Turnaround Play - Shares Offer 60+% Upside
American Shared Hospital Services Won't Stay Cheap For Long - Shares Offer 60+% Upside
ImmuCell: FDA Catalyst Could Unlock 60+% Upside
Restoration Robotics: Risky Medical Robotics Play With Explosive Growth Potential
Cryo-Cell: A Cheap, Predictable Business With Significant Growth Potential
CynergisTek: A Wonderful Business At A Wonderful Price
No, Tesla's Cars Will Not Be Fully Autonomous By The End Of 2019
Lakeland Industries Is A Bargain At <10x EV/EBIT
Electromed: At 12x EV/EBIT, This Double-Digit Grower Is A Bargain
U.S. Physical Therapy: A Good Old-Fashioned GARP Stock
The Optimal Way To Bet On The Crypto-Craze
Heska's Shares Offer Tremendous Growth At A Reasonable Price
Phibro Will Benefit From Growing Global Demand For Protein-Rich Foods
Juniper Pharmaceuticals: A High Risk, High Reward Women's Health Play
Fonar: At 10x EV/EBIT, This Medical Imaging Pioneer Is A Strong Buy
Don't Fear The Rise Of The Killer Robots
Providence Service Corporation: Underfollowed, Undervalued Medical Transportation Play
Anika Therapeutics: Robust Growth + Huge Margins At A Bargain Price
Natus Medical: Not Cheap, But Still Attractive
Emergent BioSolutions: A Very Attractive Risk/Reward Biodefense Play
Tesla Mania: This Time Ain't Different
ICON Is One Of The Cheapest CROs Around: Shares Offer 50+% Upside Potential
PAREXEL: Robust Growth + Low Valuation = Strong Buy
INC Research: A Top-Tier CRO At A Low-Tier Price
Plans Rarely Go As Planned: Why Tesla Probably Won't Sell 500,000 Cars In 2018
Charles River Laboratories Is A Wonderful Business At A Wonderful Price
CRH Medical: An Anesthesia Company That Won't Put You To Sleep
Merit Medical Systems: Double-Digit Growth At A Reasonable Valuation
LeMaitre Vascular Is A Wonderful Business At A Fair Price
Donald Trump's Key Lesson For Investors: Beware Of Experts Bearing Predictions
RTI Surgical Is An Undervalued Acquisition Target